EN
We strive to make patients-driven cellular immunotherapy innovation,
to transform cancer into a manageable condition — and ultimately cure it.
 
HomeNews and MediaCompany News
GMP certified Guangdong manufacturing site construction launched
  • 0

 

 

On May 24, 2019, TCRCure’s Guangdong manufacturing site, which includes GMP certified cell production facilities, office space, and labs for quality assurance, research and development, launched construction in Guangdong Medical Valley. This facility will encompass 5,100 square meters, with plans to be completed and operational by the end of 2019.

 


Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer